Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives.

Borderline resectable Locally advanced pancreatic cancer Neoadjuvant chemotherapy Pancreatic cancer Pancreatic duct adenocarcinoma

Journal

World journal of gastrointestinal oncology
ISSN: 1948-5204
Titre abrégé: World J Gastrointest Oncol
Pays: China
ID NLM: 101532470

Informations de publication

Date de publication:
15 Jun 2023
Historique:
received: 28 12 2022
revised: 17 02 2023
accepted: 24 04 2023
medline: 30 6 2023
pubmed: 30 6 2023
entrez: 30 6 2023
Statut: ppublish

Résumé

Pancreatic adenocarcinoma (PDAC) is one of the most common and lethal human cancers worldwide. Surgery followed by adjuvant chemotherapy offers the best chance of a long-term survival for patients with PDAC, although only approximately 20% of the patients have resectable tumors when diagnosed. Neoadjuvant chemotherapy (NACT) is recommended for borderline resectable pancreatic cancer. Several studies have investigated the role of NACT in treating resectable tumors based on the recent advances in PDAC biology, as NACT provides the potential benefit of selecting patients with favorable tumor biology and controls potential micro-metastases in high-risk patients with resectable PDAC. In such challenging cases, new potential tools, such as ct-DNA and molecular targeted therapy, are emerging as novel therapeutic options that may improve old paradigms. This review aims to summarize the current evidence regarding the role of NACT in treating non-metastatic pancreatic cancer while focusing on future perspectives in light of recent evidence.

Identifiants

pubmed: 37389109
doi: 10.4251/wjgo.v15.i6.911
pmc: PMC10302990
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

911-924

Informations de copyright

©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Références

JAMA Oncol. 2022 Nov 1;8(11):1571-1578
pubmed: 36048453
Eur J Surg Oncol. 2019 Nov;45(11):2159-2165
pubmed: 31202572
Nat Rev Clin Oncol. 2022 May;19(5):285-286
pubmed: 35194164
JAMA. 2012 Jul 11;308(2):147-56
pubmed: 22782416
Lancet Gastroenterol Hepatol. 2023 Feb;8(2):157-168
pubmed: 36521500
J Surg Oncol. 2018 Sep;118(3):455-462
pubmed: 30114330
Front Oncol. 2020 Jan 14;9:1501
pubmed: 31993372
Ann Surg. 2014 Jul;260(1):142-8
pubmed: 24901360
Ann Surg. 2019 Jun;269(6):1154-1162
pubmed: 31082915
World J Gastroenterol. 2014 Aug 21;20(31):10778-89
pubmed: 25152581
Ann Surg. 2022 Apr 1;275(4):759-768
pubmed: 33055587
Ann Surg Oncol. 2017 Sep;24(9):2777-2784
pubmed: 28608121
Gut. 2019 Jan;68(1):130-139
pubmed: 29158237
J Clin Oncol. 2022 Apr 10;40(11):1220-1230
pubmed: 35084987
Ann Surg Oncol. 2022 Dec;29(13):8503-8510
pubmed: 35976466
Cancer Chemother Pharmacol. 2019 May;83(5):975-991
pubmed: 30887178
Ann Oncol. 2017 Oct 01;28(10):2429-2435
pubmed: 28961832
Blood Cancer J. 2021 Apr 6;11(4):69
pubmed: 33824268
Br J Surg. 2011 Jan;98(1):86-92
pubmed: 21136564
J Cancer. 2021 Jan 1;12(2):539-552
pubmed: 33391450
Cancers (Basel). 2019 Aug 13;11(8):
pubmed: 31412682
Ann Surg Oncol. 2017 Oct;24(11):3203-3211
pubmed: 28718038
J Clin Oncol. 2010 Aug 1;28(22):3605-10
pubmed: 20606093
N Engl J Med. 2016 Nov 17;375(20):1920-1923
pubmed: 27959598
Ann Surg. 2021 Mar 1;273(3):579-586
pubmed: 30946073
JAMA Surg. 2020 Sep 1;155(9):832-839
pubmed: 32667641
HPB (Oxford). 2020 Feb;22(2):233-240
pubmed: 31439478
J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):590-600
pubmed: 23660962
N Engl J Med. 2017 Oct 26;377(17):1700
pubmed: 28792849
World J Hepatol. 2022 Oct 27;14(10):1862-1874
pubmed: 36340753
Pancreatology. 2018 Jan;18(1):2-11
pubmed: 29191513
Ann Gastroenterol Surg. 2022 Jul 01;6(6):862-872
pubmed: 36338582
JAMA Oncol. 2022 Sep 1;8(9):1263-1270
pubmed: 35834226
Jpn J Clin Oncol. 2019 Feb 1;49(2):190-194
pubmed: 30608598
Minerva Surg. 2022 Aug;77(4):354-359
pubmed: 34693675
JAMA Oncol. 2018 Mar 08;4(3):e173420
pubmed: 29098284
Ann Surg. 2019 Aug;270(2):340-347
pubmed: 29596120
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Ann Oncol. 1996 Apr;7(4):347-53
pubmed: 8805925
Ann Surg Oncol. 2006 Feb;13(2):150-8
pubmed: 16418882
Gastroenterology. 2016 Jan;150(1):48-63
pubmed: 26385075
Cancer Cell. 2019 Apr 15;35(4):573-587.e6
pubmed: 30975481
Nat Rev Dis Primers. 2016 Apr 21;2:16022
pubmed: 27158978
N Engl J Med. 2004 Mar 18;350(12):1200-10
pubmed: 15028824
J Gastrointest Surg. 2012 May;16(5):977-85
pubmed: 22411488
JAMA Surg. 2019 Oct 1;154(10):932-942
pubmed: 31339530
J Radiat Oncol. 2013 Dec;2(4):413-425
pubmed: 25755849
Pancreas. 2020 Mar;49(3):326-335
pubmed: 32132516
Lancet Oncol. 2017 Apr;18(4):486-499
pubmed: 28259610
Signal Transduct Target Ther. 2020 Mar 20;5(1):22
pubmed: 32296018
Int J Mol Sci. 2020 Oct 16;21(20):
pubmed: 33081107
J Am Coll Surg. 2010 Feb;210(2):e1-4
pubmed: 20113929
Strahlenther Onkol. 2015 Jan;191(1):7-16
pubmed: 25252602
PLoS Med. 2010 Apr 20;7(4):e1000267
pubmed: 20422030
Ann Surg. 2018 Mar;267(3):411-417
pubmed: 28379871
Eur Radiol. 2017 Jul;27(7):3104-3116
pubmed: 27896469
Ann Surg. 2017 Aug;266(2):333-338
pubmed: 27429020
J Natl Compr Canc Netw. 2021 Apr 1;19(4):439-457
pubmed: 33845462
Clin Chem. 2018 Apr;64(4):726-734
pubmed: 29352043
Ann Oncol. 2015 Sep;26 Suppl 5:v56-68
pubmed: 26314780
Cancers (Basel). 2020 Nov 17;12(11):
pubmed: 33213022
J Clin Oncol. 2015 Feb 20;33(6):540-9
pubmed: 25154820
Ann Oncol. 2019 Sep 1;30(9):1472-1478
pubmed: 31250894
Ann Surg. 2020 Sep 1;272(3):481-486
pubmed: 32740235
Cell. 1988 May 20;53(4):549-54
pubmed: 2453289
Cancers (Basel). 2019 Jun 19;11(6):
pubmed: 31248203
Ann Surg Oncol. 2012 Jun;19(6):2045-53
pubmed: 22258816
Surgery. 2015 Nov;158(5):1226-34
pubmed: 26138347
J Clin Oncol. 2015 Jan 20;33(3):244-50
pubmed: 25366685
J Clin Oncol. 2008 Jul 20;26(21):3496-502
pubmed: 18640930
Sci Rep. 2020 Oct 2;10(1):16425
pubmed: 33009477
Updates Surg. 2020 Mar;72(1):39-45
pubmed: 31997233
Cancer Invest. 2015 Mar;33(3):78-85
pubmed: 25647443
Protein Cell. 2018 Oct;9(10):838-847
pubmed: 28710747
Br J Surg. 2014 Jul;101(8):1000-5
pubmed: 24844590
N Engl J Med. 2017 Feb 16;376(7):e11
pubmed: 28199803
Ann Surg. 2011 Dec;254(6):882-93
pubmed: 22064622
Sci Rep. 2015 Dec 16;5:18425
pubmed: 26669280
Am J Clin Oncol. 2011 Dec;34(6):567-72
pubmed: 21150564
Ann Surg. 2015 Jan;261(1):12-7
pubmed: 25599322
J Clin Oncol. 2015 Oct 1;33(28):3124-9
pubmed: 25940717
J Exp Clin Cancer Res. 2016 Jan 04;35:1
pubmed: 26728266
Theranostics. 2019 May 31;9(14):4115-4129
pubmed: 31281535
J Cell Biochem. 2020 Jan;121(1):508-523
pubmed: 31264276
Diagnostics (Basel). 2022 Jul 05;12(7):
pubmed: 35885535
Ann Surg. 2015 Dec;262(6):1092-101
pubmed: 25587814
Ann Surg Oncol. 2018 Oct;25(11):3365-3371
pubmed: 30097739
J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):111-121
pubmed: 34581022
HPB (Oxford). 2013 Sep;15(9):661-7
pubmed: 23458352
Clin Chem. 2016 Nov;62(11):1482-1491
pubmed: 27591291
JAMA Oncol. 2016 Jul 1;2(7):937-40
pubmed: 27124835
Clin Cancer Res. 2022 Aug 15;28(16):3433-3442
pubmed: 35552673
Lancet Oncol. 2016 Jun;17(6):801-810
pubmed: 27160474
Ann Surg. 2016 Sep;264(3):457-63
pubmed: 27355262
Br J Surg. 2019 May;106(6):756-764
pubmed: 30830974
J Clin Oncol. 2008 Jul 20;26(21):3487-95
pubmed: 18640929
Diagnostics (Basel). 2018 Oct 29;8(4):
pubmed: 30380690
Br J Cancer. 1996 Jan;73(1):101-5
pubmed: 8554969
HPB (Oxford). 2017 Nov;19(11):1001-1007
pubmed: 28838632
Ann Surg. 2019 Sep;270(3):400-413
pubmed: 31283563
N Engl J Med. 2018 Dec 20;379(25):2395-2406
pubmed: 30575490
JCO Precis Oncol. 2021 Jan 12;5:
pubmed: 34250394
Cancer Chemother Pharmacol. 2019 Nov;84(5):1003-1015
pubmed: 31482224
Gut. 2018 Dec;67(12):2142-2155
pubmed: 29080858
Cancer Res. 2014 Jul 15;74(14):3947-58
pubmed: 24986516
J Gastrointest Oncol. 2021 Oct;12(5):2475-2483
pubmed: 34790408
Ann Surg. 2022 Jun 27;:
pubmed: 35758505
J Hematol Oncol. 2020 Oct 2;13(1):130
pubmed: 33008426
Digestion. 1997;58(6):570-7
pubmed: 9438604
BMJ Open. 2019 Dec 8;9(12):e033452
pubmed: 31818843
Cancer. 2015 Jan 15;121(2):269-75
pubmed: 25224030
World J Surg. 2010 Nov;34(11):2648-61
pubmed: 20607257
Ann Hepatobiliary Pancreat Surg. 2018 Nov;22(4):386-396
pubmed: 30588531
J Clin Oncol. 2008 May 20;26(15):2526-31
pubmed: 18487569
Pancreatology. 2017 Mar - Apr;17(2):285-290
pubmed: 28139399
J Hematol Oncol. 2019 Dec 4;12(1):130
pubmed: 31801585
J Surg Oncol. 2018 Apr;117(5):1073-1083
pubmed: 29448308
HPB (Oxford). 2017 Jun;19(6):483-490
pubmed: 28410913

Auteurs

Gianluca Cassese (G)

Department of Clinical Medicine and Surgery, Division of Minimally Invasive HPB Surgery and Transplantation Service, Federico II University Hospital, Naples 80131, Italy.

Ho-Seong Han (HS)

Department of Surgery, Seoul National University College of Medicine, Seongnam 13620, Gyeonggi-do, South Korea. hanhs@snubh.org.

Yoo-Seok Yoon (YS)

Department of Surgery, Seoul National University College of Medicine, Seongnam 13620, Gyeonggi-do, South Korea.

Jun Suh Lee (JS)

Department of Surgery, Seoul National University College of Medicine, Seongnam 13620, Gyeonggi-do, South Korea.

Boram Lee (B)

Department of Surgery, Seoul National University College of Medicine, Seongnam 13620, Gyeonggi-do, South Korea.

Antonio Cubisino (A)

Department of HPB Surgery and Transplantation, Beaujon Hospital, Clichy 92110, France.

Fabrizio Panaro (F)

Department of Digestive Surgery and Liver Transplantation, CHU Montpellier, Montpellier 34100, France.

Roberto Ivan Troisi (RI)

Department of Clinical Medicine and Surgery, Division of Minimally Invasive HPB Surgery and Transplantation Service, Federico II University Hospital, Naples 80131, Italy.

Classifications MeSH